VA's Payment for Leqembi a Positive Move for Biogen.
TL;DR Summary
The Veterans Health Administration will cover Biogen and Eisai's Alzheimer's disease therapy, Leqembi, for the patients it serves, under certain restrictive criteria. However, the goal of full Medicare coverage remains a long way off.
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
66%
101 → 34 words
Want the full story? Read the original article
Read on Barron's